RA
ALKS icon

Royce & Associates’s Alkermes ALKS Stock Holding History

Royce & Associates’s Portfolio ALKS Stock Details ALKS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.04M Buy
58,072
+2,389
+4% +$93.3K 0.02% 558
2026
Q1 		$1.97M Buy
55,683
+7,673
+16% +$238K 0.02% 578
2025
Q4 		$1.34M Sell
48,010
-1,759
-4% -$52.7K 0.01% 645
2025
Q3 		$1.49M Buy
49,769
+37
+0.1% +$1.04K 0.01% 621
2025
Q2 		$1.42M Buy
49,732
+2,545
+5% +$75.7K 0.01% 641
2025
Q1 		$1.56M Sell
47,187
-7,244
-13% -$236K 0.02% 628
2024
Q4 		$1.57M Sell
54,431
-13,197
-20% -$379K 0.01% 660
2024
Q3 		$1.89M Buy
67,628
+22,356
+49% +$596K 0.02% 633
2024
Q2 		$1.09M Buy
45,272
+13,426
+42% +$329K 0.01% 708
2024
Q1 		$862K Buy
+31,846
New +$904K 0.01% 739

Other funds holding ALKS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Royce & Associates's ALKS Position: Q2 2026 in Review

Royce & Associates increased its Alkermes (ALKS) stake by 4.3% in Q2 2026, buying an estimated $93.3K and bringing the position to 58,072 shares worth $3.04M. The position accounts for 0.02% of the portfolio, ranked #558.

Royce & Associates first reported a position in ALKS in Q1 2024 and has held it in 10 quarters since. 424 funds tracked by Wall St. Rank hold ALKS as of Q2 2026.

  • Royce & Associates held 58,072 shares of Alkermes worth $3.04M as of Q2 2026.
  • Royce & Associates bought 2,389 Alkermes shares in Q2 2026, an estimated $93.3K.
  • Alkermes made up 0.02% of Royce & Associates's portfolio in Q2 2026, its #558 holding.
  • Royce & Associates first reported a position in Alkermes in Q1 2024 and has held it in 10 quarters since.
  • 424 funds tracked by Wall St. Rank held Alkermes as of Q2 2026.

Based on Royce & Associates's 13F filing for Q2 2026, filed 14 Aug 2026.